ID: PMRREP31924
Format: PPT*, PDF, EXCEL
Last Updated: 28 February 2023
Industry: Healthcare
Number of Pages: 195
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Pipeline Assessment
4.4. Recent Product Approval and Launches
4.5. PESTLE Analysis
4.6. Porter’s Analysis
4.7. Regulatory Scenario
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Allergy Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growth of the Top Companies
5.2.2. Rising Prevalence of Various Types of Allergies
5.2.3. Cost of Products
5.2.4. Product and Stock Availability
5.2.5. Mergers and Acquisitions
5.2.6. Changing Lifestyle
5.2.7. Strong Product Pipeline
5.2.8. Growing Corporate Agreements
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Immunotherapy
6.1.3. BY Indication
6.1.4. By Allergen
6.1.5. By Distribution Channel
6.1.6. By Region
6.2. 2022 Market Scenario
7. Global Market Volume (in Units) Analysis 2015-2022 and Forecast, 2023-2033
7.1. Historical Volume (in Units) Analysis, 2015-2022
7.2. Current and Future Volume (in Units) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033
9.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2015-2022
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2023-2033
10.3.1. SLIT Tablets
10.3.1.1. Odactra
10.3.1.2. Grastek
10.3.1.3. Ragwitek
10.3.1.4. Oralair
10.3.1.5. Actair
10.3.1.6. Others
10.3.2. Oral
10.3.2.1. Palforzia
10.3.2.2. Others
10.3.3. Injections
10.3.4. Others
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Immunotherapy
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Immunotherapy, 2015-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Immunotherapy, 2023-2033
11.3.1. Sublingual Immunotherapy (SLIT)
11.3.2. Subcutaneous Immunotherapy (SCIT)
11.3.2.1. Specific Immunotherapy
11.3.3. Others
11.4. Market Attractiveness Analysis By Immunotherapy
12. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Indication
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
12.3.1. Allergic Rhinitis
12.3.2. Allergic Asthma
12.3.3. Food Allergy
12.3.4. Atopic Dermatitis
12.3.5. Others
12.4. Market Attractiveness Analysis By Indication
13. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Allergen
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Allergen, 2015-2022
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergen, 2023-2033
13.3.1. Pollens
13.3.1.1. Grass Pollens
13.3.1.2. Weed Pollens
13.3.1.3. Tree Pollens
13.3.2. House Dust Mites (HDM)
13.3.3. Mould
13.3.4. Animal Dander
13.3.5. Bee Venom
13.3.6. Cockroaches/Insects
13.3.7. Others
13.4. Market Attractiveness Analysis By Allergen
14. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2022
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
14.3.1. Institutional Sales
14.3.1.1. Government Hospitals
14.3.1.2. Semi-Government Hospitals
14.3.1.3. Private Hospitals
14.3.2. Retail Sales
14.3.2.1. Retail Pharmacy
14.3.2.2. Drug Stores
14.3.2.3. Online Pharmacy
14.4. Market Attractiveness Analysis By Distribution Channel
15. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. South Asia
15.3.5. East Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2015-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By Immunotherapy
16.3.4. By Indication
16.3.5. By Allergen
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Immunotherapy
16.4.4. By Indication
16.4.5. By Allergen
16.4.6. By Distribution Channel
16.5. Country Level Analysis & Forecast
16.5.1. U.S. Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Immunotherapy
16.5.1.2.3. By Indication
16.5.1.2.4. By Allergen
16.5.1.2.5. By Distribution Channel
16.5.2. Canada Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Immunotherapy
16.5.2.2.3. By Indication
16.5.2.2.4. By Allergen
16.5.2.2.5. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Latin America Market Analysis 2015-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By Immunotherapy
17.3.4. By Indication
17.3.5. By Allergen
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Immunotherapy
17.4.4. By Indication
17.4.5. By Allergen
17.4.6. By Distribution Channel
17.5. Country Level Analysis & Forecast
17.5.1. Brazil Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Immunotherapy
17.5.1.2.3. By Indication
17.5.1.2.4. By Allergen
17.5.1.2.5. By Distribution Channel
17.5.2. Mexico Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Immunotherapy
17.5.2.2.3. By Indication
17.5.2.2.4. By Allergen
17.5.2.2.5. By Distribution Channel
17.5.3. Argentina Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Immunotherapy
17.5.3.2.3. By Indication
17.5.3.2.4. By Allergen
17.5.3.2.5. By Distribution Channel
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Europe Market Analysis 2015-2022 and Forecast 2023-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. France
18.3.1.3. Italy
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. Russia
18.3.1.7. BENELUX
18.3.1.8. Rest of Europe
18.3.2. By Product
18.3.3. By Immunotherapy
18.3.4. By Indication
18.3.5. By Allergen
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Immunotherapy
18.4.4. By Indication
18.4.5. By Allergen
18.4.6. By Distribution Channel
18.5. Country Level Analysis & Forecast
18.5.1. Germany Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Immunotherapy
18.5.1.2.3. By Indication
18.5.1.2.4. By Allergen
18.5.1.2.5. By Distribution Channel
18.5.2. France Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Immunotherapy
18.5.2.2.3. By Indication
18.5.2.2.4. By Allergen
18.5.2.2.5. By Distribution Channel
18.5.3. Italy Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Immunotherapy
18.5.3.2.3. By Indication
18.5.3.2.4. By Allergen
18.5.3.2.5. By Distribution Channel
18.5.4. U.K. Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Product
18.5.4.2.2. By Immunotherapy
18.5.4.2.3. By Indication
18.5.4.2.4. By Allergen
18.5.4.2.5. By Distribution Channel
18.5.5. Spain Market Analysis
18.5.5.1. Introduction
18.5.5.2. Market Analysis and Forecast by Market Taxonomy
18.5.5.2.1. By Product
18.5.5.2.2. By Immunotherapy
18.5.5.2.3. By Indication
18.5.5.2.4. By Allergen
18.5.5.2.5. By Distribution Channel
18.5.6. Russia Market Analysis
18.5.6.1. Introduction
18.5.6.2. Market Analysis and Forecast by Market Taxonomy
18.5.6.2.1. By Product
18.5.6.2.2. By Immunotherapy
18.5.6.2.3. By Indication
18.5.6.2.4. By Allergen
18.5.6.2.5. By Distribution Channel
18.5.7. BENELUX Market Analysis
18.5.7.1. Introduction
18.5.7.2. Market Analysis and Forecast by Market Taxonomy
18.5.7.2.1. By Product
18.5.7.2.2. By Immunotherapy
18.5.7.2.3. By Indication
18.5.7.2.4. By Allergen
18.5.7.2.5. By Distribution Channel
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. South Asia Market Analysis 2015-2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Thailand
19.3.1.3. Indonesia
19.3.1.4. Malaysia
19.3.1.5. Rest of South Asia
19.3.2. By Product
19.3.3. By Immunotherapy
19.3.4. By Indication
19.3.5. By Allergen
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Immunotherapy
19.4.4. By Indication
19.4.5. By Allergen
19.4.6. By Distribution Channel
19.5. Country Level Analysis & Forecast
19.5.1. India Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Immunotherapy
19.5.1.2.3. By Indication
19.5.1.2.4. By Allergen
19.5.1.2.5. By Distribution Channel
19.5.2. Thailand Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Immunotherapy
19.5.2.2.3. By Indication
19.5.2.2.4. By Distribution Channel
19.5.3. Indonesia Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Immunotherapy
19.5.3.2.3. By Indication
19.5.3.2.4. By Allergen
19.5.3.2.5. By Distribution Channel
19.5.4. Malaysia Market Analysis
19.5.4.1. Introduction
19.5.4.2. Market Analysis and Forecast by Market Taxonomy
19.5.4.2.1. By Product
19.5.4.2.2. By Immunotherapy
19.5.4.2.3. By Indication
19.5.4.2.4. By Allergen
19.5.4.2.5. By Distribution Channel
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. East Asia Market Analysis 2015-2022 and Forecast 2023-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Product
20.3.3. By Immunotherapy
20.3.4. By Indication
20.3.5. By Allergen
20.3.6. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Immunotherapy
20.4.4. By Indication
20.4.5. By Allergen
20.4.6. By Distribution Channel
20.5. Country Level Analysis & Forecast
20.5.1. China Market Analysis
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Immunotherapy
20.5.1.2.3. By Indication
20.5.1.2.4. By Allergen
20.5.1.2.5. By Distribution Channel
20.5.2. Japan Market Analysis
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Immunotherapy
20.5.2.2.3. By Indication
20.5.2.2.4. By Allergen
20.5.2.2.5. By Distribution Channel
20.5.3. South Korea Market Analysis
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Immunotherapy
20.5.3.2.3. By Indication
20.5.3.2.4. By Allergen
20.5.3.2.5. By Distribution Channel
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Oceania Market Analysis 2015-2022 and Forecast 2023-2033
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By Immunotherapy
21.3.4. By Indication
21.3.5. By Allergen
21.3.6. By Distribution Channel
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Immunotherapy
21.4.4. By Indication
21.4.5. By Allergen
21.4.6. By Distribution Channel
21.5. Country Level Analysis & Forecast
21.5.1. Australia Market Analysis
21.5.1.1. Introduction
21.5.1.2. Market Analysis and Forecast by Market Taxonomy
21.5.1.2.1. By Product
21.5.1.2.2. By Immunotherapy
21.5.1.2.3. By Indication
21.5.1.2.4. By Allergen
21.5.1.2.5. By Distribution Channel
21.5.2. New Zealand Market Analysis
21.5.2.1. Introduction
21.5.2.2. Market Analysis and Forecast by Market Taxonomy
21.5.2.2.1. By Product
21.5.2.2.2. By Immunotherapy
21.5.2.2.3. By Indication
21.5.2.2.4. By Allergen
21.5.2.2.5. By Distribution Channel
21.6. Market Trends
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
22. Middle East and Africa Market Analysis 2015-2022 and Forecast 2023-2033
22.1. Introduction
22.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2015-2022
22.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Türkiye
22.3.1.3. Northern Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By Immunotherapy
22.3.4. By Indication
22.3.5. By Allergen
22.3.6. By Distribution Channel
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By Immunotherapy
22.4.4. By Indication
22.4.5. By Allergen
22.4.6. By Distribution Channel
22.5. Country Level Analysis & Forecast
22.5.1. GCC Countries Market Analysis
22.5.1.1. Introduction
22.5.1.2. Market Analysis and Forecast by Market Taxonomy
22.5.1.2.1. By Product
22.5.1.2.2. By Immunotherapy
22.5.1.2.3. By Indication
22.5.1.2.4. By Allergen
22.5.1.2.5. By Distribution Channel
22.5.2. Türkiye Market Analysis
22.5.2.1. Introduction
22.5.2.2. Market Analysis and Forecast by Market Taxonomy
22.5.2.2.1. By Product
22.5.2.2.2. By Immunotherapy
22.5.2.2.3. By Indication
22.5.2.2.4. By Allergen
22.5.2.2.5. By Distribution Channel
22.5.3. Northern Africa Market Analysis
22.5.3.1. Introduction
22.5.3.2. Market Analysis and Forecast by Market Taxonomy
22.5.3.2.1. By Product
22.5.3.2.2. By Immunotherapy
22.5.3.2.3. By Indication
22.5.3.2.4. By Allergen
22.5.3.2.5. By Distribution Channel
22.5.4. South Africa Market Analysis
22.5.4.1. Introduction
22.5.4.2. Market Analysis and Forecast by Market Taxonomy
22.5.4.2.1. By Product
22.5.4.2.2. By Immunotherapy
22.5.4.2.3. By Indication
22.5.4.2.4. By Allergen
22.5.4.2.5. By Distribution Channel
22.6. Market Trends
22.7. Key Market Participants - Intensity Mapping
22.8. Drivers and Restraints - Impact Analysis
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Branding and Promotional Strategies
24.3. Key Development Analysis
24.4. Competition Deep Dive
24.4.1. ALK Abello
24.4.1.1. Overview
24.4.1.2. Product Portfolio
24.4.1.3. Key Financials
24.4.1.4. SWOT Analysis
24.4.1.5. Sales Footprint
24.4.1.6. Strategy Overview
24.4.2. Stallergenes Greer
24.4.2.1. Overview
24.4.2.2. Product Portfolio
24.4.2.3. Key Financials
24.4.2.4. SWOT Analysis
24.4.2.5. Sales Footprint
24.4.2.6. Strategy Overview
24.4.3. Allergy Therapeutics
24.4.3.1. Overview
24.4.3.2. Product Portfolio
24.4.3.3. Key Financials
24.4.3.4. SWOT Analysis
24.4.3.5. Sales Footprint
24.4.3.6. Strategy Overview
24.4.4. Aimmune Therapeutics
24.4.4.1. Overview
24.4.4.2. Product Portfolio
24.4.4.3. Key Financials
24.4.4.4. SWOT Analysis
24.4.4.5. Sales Footprint
24.4.4.6. Strategy Overview
24.4.5. Anergis
24.4.5.1. Overview
24.4.5.2. Product Portfolio
24.4.5.3. Key Financials
24.4.5.4. SWOT Analysis
24.4.5.5. Sales Footprint
24.4.5.6. Strategy Overview
24.4.6. Arrayit Corporation
24.4.6.1. Overview
24.4.6.2. Product Portfolio
24.4.6.3. Key Financials
24.4.6.4. SWOT Analysis
24.4.6.5. Sales Footprint
24.4.6.6. Strategy Overview
24.4.7. Biomay AG
24.4.7.1. Overview
24.4.7.2. Product Portfolio
24.4.7.3. Key Financials
24.4.7.4. SWOT Analysis
24.4.7.5. Sales Footprint
24.4.7.6. Strategy Overview
24.4.8. HAL Allergy Group
24.4.8.1. Overview
24.4.8.2. Product Portfolio
24.4.8.3. Key Financials
24.4.8.4. SWOT Analysis
24.4.8.5. Sales Footprint
24.4.8.6. Strategy Overview
24.4.9. DBV Technologies
24.4.9.1. Overview
24.4.9.2. Product Portfolio
24.4.9.3. Key Financials
24.4.9.4. SWOT Analysis
24.4.9.5. Sales Footprint
24.4.9.6. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology
